As a child I suffered from Asthma. It was pretty severe and a few times I was hospitalised with it. Sure, there was medication I could (and did) take, but I wanted more from the medical profession than, ‘try this medication and see how you get on’. To me, that felt like I was being brushed off a bit. You’ll be glad to know that these days I am no longer affected by Asthma, but if I was, I would be very interested in using technology to log and map my attacks to see if there were patterns, I could follow and therefore manage my Asthma better.
The app and peak flow meter from AsthmaMD is a leap forward in the monitoring of asthma attacks and the collection of data. Founder of AsthmaMD, Dr. Sam Pejham and Salim Madjd, who is the start-ups’ app designer, have said that AsthmaMD 3.0 is the firm’s latest product and it is “essentially a brand new app coded from scratch and it’s our most significant release yet.” AsthmaMD 3.0 makes it simpler for physicians to create easy to follow action plans or even a written plan, which is designed for each individual patient to guide day-to-day care, as well as management of symptoms that are becoming increasingly worse.
The platform is now inclusive of the patent-pending asthma action plan, (or a treatment plan) for patients, that is developed with the assistance of their doctors. The app also has an integrated medication reminder system and the ability to track and log asthma symptoms from numerous devices, with data saved to AsthmaMD’s very own secure cloud. The AsthmaMD’s peak flow meter, which is a key part of its monetization strategy, is now available in some Walgreens and CVS stores.
“We had to find a way to continue providing the app for free while running a business. We pivoted and analyzed various options that would still allowed us to stay true to our mission of modernizing asthma care,” wrote Madjd and Pejham.
AsthmaMD 3.0 not only makes it simpler for doctors to create individual asthma plans, but the platform is then broken down into simple interactive steps for the patient to follow. “Eighty percent of asthmatics do not have proper education and understanding of the differences between control and rescue medications. With AsthmaMD 3.0 we made education an implicit part of the experience. With every opportunity we are delineating the differences in these medications…Over 55% of asthmatics are unaware their asthma is not well controlled, which has shown to have direct correlation of increase risk of hospitalization, urgent medical needs, and reduced quality of life.” they added. Patients can send the data to their doctors, who can then monitor how effectively each action plan is working.
As always, if you would like to leave a sensible comment, then please do so in the comments section below.